All-Digital AIDS Wal
All-Digital AIDS Walk Los Angeles 2021 Continues to Fight the HIV/AIDS Epidemic in Los Angeles County!
November 18, 2021 13:34 ET | APLA Health
Los Angeles, CA, Nov. 18, 2021 (GLOBE NEWSWIRE) -- This year’s all-digital AIDS Walk Los Angeles ended this past week, with hundreds of individual and team fundraisers, community partners, and...
Exavir Therapeutics announces preclinical data demonstrating complete elimination of HIV from human cells with LNP-delivered Tat-targeted CRISPR-Cas9
November 10, 2021 07:30 ET | Exavir Therapeutics
Early candidate from XVIR-TAT series demonstrated genetic elimination of HIV and robust anti-retroviral activity with CRISPR-Cas9 based excision Exavir lipid nanoparticles (LNPs) with mRNA...
VIR_logo_large.jpg
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2021 Financial Results
November 04, 2021 16:05 ET | Vir Biotechnology, Inc.
– To date, binding sales agreements for more than 420,000 doses of sotrovimab secured worldwide – – In the third quarter, well over 50,000 doses delivered and $102.4M of sotrovimab collaboration...
TIP_link_300x300.jpg
Personal Lubricants Market Size ($2,933.62Mn by 2028) Lead by Water-Based Lubricant (10.9% CAGR) Impact of Coronavirus Outbreak and Global Analysis & Forecast by TheInsightPartners.com
October 29, 2021 12:47 ET | The Insight Partners
New York, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Personal Lubricants Market: Key InsightsAccording to our new research study on Personal Lubricants Market Size and Forecast to 2028 - COVID-19 Impact and...
CytoDyn color logo - no R.png
CytoDyn Announces FDA Accepts Revised Rolling Review Timeline for Resubmission of its BLA
October 28, 2021 00:41 ET | CytoDyn Inc.
Management expects the non-clinical and CMC sections of the BLA to be resubmitted to FDA in November VANCOUVER, Washington, Oct. 27, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn"...
Nouveau Logo communiqué de presse.JPG
Theratechnologies annonce un accord de remboursement en Italie pour Trogarzo® pour les patients admissibles présentant une infection par le VIH-1 multirésistante
October 26, 2021 02:00 ET | Theratechnologies
MONTRÉAL, 26 oct. 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX : TH) (NASDAQ : THTX), société biopharmaceutique axée sur le développement et la commercialisation de...
Nouveau Logo communiqué de presse.JPG
Theratechnologies Announces Reimbursement Agreement in Italy for Trogarzo® for Eligible Patients With Multi-Drug Resistant HIV-1
October 26, 2021 02:00 ET | Theratechnologies
MONTREAL, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of...
VIR_logo_large.jpg
Vir Biotechnology to Provide Corporate Update and Report Third Quarter 2021 Financial Results on November 4, 2021
October 21, 2021 16:05 ET | Vir Biotechnology, Inc.
SAN FRANCISCO, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide a corporate update and report financial results for the third quarter...
Black-Enochian-Primary-Logo.jpg
Enochian BioSciences Announces the Successful Completion of an FDA Pre-IND for a Potential Cure for HIV: The Second Pre-IND in 1 month
October 18, 2021 07:00 ET | Enochian BioSciences, Inc.
LOS ANGELES, Oct. 18, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) − Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today...
American Gene Technologies Appoints Dr. Marcus A. Conant as Special Advisor to the CEO
October 01, 2021 13:25 ET | American Gene Technologies
ROCKVILLE, Md., Oct. 01, 2021 (GLOBE NEWSWIRE) -- American Gene Technologies (AGT) announces the appointment of Dr. Marcus A. Conant, a leading dermatologist in the U.S. and one of the first...